Insider Holders & Insider Ownership - INOVIO PHARMACEUTICALS INC. (INO)

List of insiders holdings for INOVIO PHARMACEUTICALS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
MARXE AUSTIN W & GREENHOUSE DAVID M
10% Owner
2013-10-10 16:27:406,900,000
0
6,900,000Form 13G
Kim Jong Joseph
Chief Executive Officer
2022-03-14 16:36:281,562,013
923,373
2,485,386Form 4
Rassas Kevin
Sr. VP Business Development
2009-11-18 13:20:20824,208
0
824,208Form 4/A
RIGGINS BROOK G
V.P. Finance & Corp. Comm.
2003-11-25 16:16:47537,500
0
537,500Form 4/A
COLLINS MORTON
Director
2019-05-13 15:56:56168,130
197,100
365,230Form 4
POLITESKI GORDON
Director
2003-09-19 14:40:58343,750
0
343,750Form 4
White Cheryl Jo
Chief Medical Officer
2009-07-01 17:05:59196,240
0
196,240Form 4
Sardesai Niranjan
Chief Operating Officer
2018-03-13 18:36:31189,352
0
189,352Form 4
Bagarazzi Mark
Chief Medical Officer
2019-03-07 17:12:34155,805
0
155,805Form 4
Singleton Walter
V.P. Clinical Regulatory Affai
2004-11-15 18:41:06125,000
0
125,000Form 3
DHILLON AVTAR S
Director
2018-12-06 17:17:19106,002
0
106,002Form 4
Cabrera Angel
Director
2020-05-08 18:17:2775,602
0
75,602Form 4
HEPPELL JAMES L
Director
2008-08-18 17:47:2775,000
0
75,000Form 4
DHILLON PUNIT
VP, Finance & Operations
2009-10-02 18:05:1375,000
0
75,000Form 4
NG TEE KHIANG
Director
2009-10-02 18:07:4775,000
0
75,000Form 4
Shea Jacqueline Elizabeth
Chief Executive Officer
2024-05-16 16:59:3169,135
0
69,135Form 4
McHugh George F. III
Vice President, Operations
2006-03-10 18:51:0045,000
0
45,000Form 4
MAHMOUD ADEL
Director
2018-05-14 18:10:4543,339
0
43,339Form 4
Fons Michael
VP, Corporate Development
2009-10-02 18:05:3340,000
0
40,000Form 4
Wells Keith H
Director
2011-05-17 19:35:3735,000
0
35,000Form 4
Williams David J
Director
2010-06-18 16:44:4235,000
0
35,000Form 4
KIES PETER
CFO
2024-05-16 17:10:0033,909
375
34,284Form 4
Humeau Laurent
Chief Scientific Officer
2024-05-16 17:08:1333,879
0
33,879Form 4
Chong Chin Cheong
Director
2008-12-10 06:10:1630,000
0
30,000Form 4
GAN BENG LEE
Director
2008-05-07 19:49:4130,000
0
30,000Form 4
THEEUWES FELIX
Director
2006-06-09 17:57:0925,000
0
25,000Form 4
RABUSSAY DIETMAR P
V.P. Research & Development
2007-03-09 19:22:2425,000
0
25,000Form 4
Wysenski Nancy
Director
2016-05-16 17:18:3925,000
0
25,000Form 4
Rieder Robert William
Director
2008-05-06 19:02:2815,000
0
15,000Form 4
RIETIKER STEPHEN
Director
2008-05-06 19:01:4615,000
0
15,000Form 4
Bandali Riaz Amirali
Director
2008-05-06 19:03:0515,000
0
15,000Form 4
ESMAIL TAZDIN
Director
2008-05-06 19:03:3015,000
0
15,000Form 4
Bickerstaff George
Director
2018-03-22 14:17:0212,270
0
12,270Form 4
LARSON EUGENE A
Director
2005-05-16 15:55:5910,000
0
10,000Form 4
Sumner Michael John
Chief Medical Officer
2024-12-18 19:01:5210,000
0
10,000Form 4
DANSEY ROGER D
Director
2024-05-22 16:49:535,084
0
5,084Form 4
BENITO SIMON X
Director
2024-05-22 16:50:115,084
0
5,084Form 4
YARNO WENDY L
Director
2024-05-22 16:50:345,084
0
5,084Form 4
Weiner David B.
Director
2024-05-22 16:51:005,084
0
5,084Form 4
Miller Ann Calby
Director
2024-05-22 16:51:165,084
0
5,084Form 4
Shepard Jay
Director
2024-05-22 16:51:385,084
0
5,084Form 4
Zoth Lota S.
Director
2024-05-22 16:51:585,084
0
5,084Form 4
GOODENEW ROBERT S
V.P. Corporate Development
2006-12-22 13:52:210
0
0Form 4